• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mckeown esophagogastrectomy.麦基翁食管胃切除术
J Thorac Dis. 2014 May;6 Suppl 3(Suppl 3):S322-4. doi: 10.3978/j.issn.2072-1439.2014.03.28.
2
A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown.微创食管切除术围手术期并发症的标准化比较:Ivor Lewis 与 McKeown 术式。
Surg Endosc. 2018 Jan;32(1):204-211. doi: 10.1007/s00464-017-5660-4. Epub 2017 Jun 22.
3
Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer.微创McKeown食管癌切除术的最新经验
World J Gastroenterol. 2015 Dec 7;21(45):12873-81. doi: 10.3748/wjg.v21.i45.12873.
4
Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy.倾向性评分匹配分析比较微创 Ivor Lewis 与微创 McKeown 食管切除术。
Ann Surg. 2020 Jan;271(1):128-133. doi: 10.1097/SLA.0000000000002982.
5
Effectiveness and safety of minimally invasive Ivor Lewis and McKeown oesophagectomy in Chinese patients with stage IA-IIIB oesophageal squamous cell cancer: a multicentre, non-interventional and observational study.微创Ivor Lewis和McKeown食管癌切除术治疗中国IA-IIIB期食管鳞状细胞癌患者的有效性和安全性:一项多中心、非干预性观察性研究
Interact Cardiovasc Thorac Surg. 2020 Jun 1;30(6):812-819. doi: 10.1093/icvts/ivaa038.
6
Clinical analysis of minimally invasive McKeown esophagectomy in a single center by a single medical group.单中心单医疗组微创 McKeown 食管癌切除术的临床分析。
J Zhejiang Univ Sci B. 2018;19(9):718-725. doi: 10.1631/jzus.B1800329.
7
Robot-Assisted Mckeown Esophagectomy is Feasible After Neoadjuvant Chemoradiation. Our Initial Experience.新辅助放化疗后机器人辅助麦克尤恩食管癌切除术是可行的。我们的初步经验。
Indian J Surg. 2018 Feb;80(1):24-29. doi: 10.1007/s12262-016-1533-7. Epub 2016 Jul 28.
8
Improving outcomes after esophagectomy: the importance of preventing postoperative pneumonia.改善食管切除术后的预后:预防术后肺炎的重要性。
Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Sep;14(9):660-6.
9
Modified McKeown minimally invasive esophagectomy for esophageal cancer: a 5-year retrospective study of 142 patients in a single institution.改良McKeown微创食管癌切除术:单中心142例患者的5年回顾性研究
PLoS One. 2013 Dec 20;8(12):e82428. doi: 10.1371/journal.pone.0082428. eCollection 2013.
10
Minimally invasive esophagectomy and its current role in esophageal cancer.微创食管切除术及其在食管癌治疗中的当前作用。
Minerva Chir. 2014 Dec;69(6):363-370. Epub 2014 Oct 10.

引用本文的文献

1
Neoadjuvant chemoradiation therapy application in radical esophagectomy surgery: Safety and feasibility: A descriptive study in Vietnam.新辅助放化疗在食管癌根治性手术中的应用:安全性与可行性:越南的一项描述性研究
Medicine (Baltimore). 2025 Jan 31;104(5):e41429. doi: 10.1097/MD.0000000000041429.
2
Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects.食管癌药物递送的机遇:当前治疗方法和未来前景。
Mol Pharm. 2024 Jul 1;21(7):3103-3120. doi: 10.1021/acs.molpharmaceut.4c00246. Epub 2024 Jun 18.
3
Trans-thoracic versus trans-hiatal resection for oesophageal carcinoma: a retrospective comparative study of a single-centre case series.经胸与经腹食管癌切除术:单中心病例系列的回顾性比较研究
Cardiothorac Surg. 2020;28(1):25. doi: 10.1186/s43057-020-00035-y. Epub 2020 Nov 25.
4
Gastro-Intestinal Disorders and Micronutrient Deficiencies following Oncologic Esophagectomy and Gastrectomy.肿瘤性食管切除术和胃切除术后的胃肠道疾病与微量营养素缺乏
Cancers (Basel). 2023 Jul 9;15(14):3554. doi: 10.3390/cancers15143554.
5
Esophageal cancer operation in the COVID-19 era: are the outcomes different from its past in an observational cohort study?COVID-19 时代的食管癌手术:在一项观察性队列研究中,其结果与过去有不同吗?
Ann Med Surg (Lond). 2023 May 25;85(7):3303-3307. doi: 10.1097/MS9.0000000000000923. eCollection 2023 Jul.
6
Longer interval between neoadjuvant chemoradiotherapy and surgery is associated with improved pathological response, but does not accurately estimate survival in patients with resectable esophageal cancer.新辅助放化疗与手术之间的间隔时间延长与病理反应改善相关,但不能准确估计可切除食管癌患者的生存率。
Oncol Lett. 2023 Mar 3;25(4):155. doi: 10.3892/ol.2023.13741. eCollection 2023 Apr.
7
Outcomes of Minimally Invasive and Robot-Assisted Esophagectomy for Esophageal Cancer.微创与机器人辅助食管癌切除术的疗效
Cancers (Basel). 2022 Jul 28;14(15):3667. doi: 10.3390/cancers14153667.
8
Selection of minimally invasive surgical approaches for treating esophageal cancer.治疗食管癌的微创外科手术方法选择。
Thorac Cancer. 2022 Aug;13(15):2100-2105. doi: 10.1111/1759-7714.14533. Epub 2022 Jun 15.
9
Update on Management of Squamous Cell Esophageal Cancer.食管鳞状细胞癌管理的最新进展
Curr Oncol Rep. 2022 Mar;24(3):375-385. doi: 10.1007/s11912-021-01153-4. Epub 2022 Feb 10.
10
A Comparative Study between the Postoperative Complications of Stripping Esophagectomy and Classic (Orringer's Technique) Esophagectomy.剥脱性食管切除术与经典(奥林格技术)食管切除术后并发症的比较研究
Surg J (N Y). 2022 Feb 1;8(1):e34-e40. doi: 10.1055/s-0041-1736666. eCollection 2022 Jan.

本文引用的文献

1
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
2
Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study.英国开放性与微创食管癌切除术治疗癌症的短期预后:基于人群的全国性研究。
Ann Surg. 2012 Feb;255(2):197-203. doi: 10.1097/SLA.0b013e31823e39fa.
3
Esophageal and esophagogastric junction cancers.食管癌和食管胃交界癌。
J Natl Compr Canc Netw. 2011 Aug 1;9(8):830-87. doi: 10.6004/jnccn.2011.0072.
4
A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia.全面评估食管癌术后的误吸可降低术后肺炎的发生率。
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1266-71. doi: 10.1016/j.jtcvs.2010.08.038. Epub 2010 Sep 29.
5
Comparison of the outcomes between open and minimally invasive esophagectomy.开放手术与微创食管切除术的疗效比较。
Ann Surg. 2007 Feb;245(2):232-40. doi: 10.1097/01.sla.0000225093.58071.c6.
6
Respiratory complications after esophagectomy.食管癌切除术后的呼吸并发症。
Thorac Surg Clin. 2006 Feb;16(1):35-48, vi. doi: 10.1016/j.thorsurg.2006.01.007.
7
Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.胃食管交界腺癌切除术后的死亡率和发病率:预测因素
J Am Coll Surg. 2005 Aug;201(2):253-62. doi: 10.1016/j.jamcollsurg.2005.02.002.
8
Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy.食管癌扩大切除术后的肺部并发症与更差的短期和长期预后相关。
J Surg Oncol. 2004 Nov 1;88(2):71-7. doi: 10.1002/jso.20137.
9
Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer.食管癌切除术后肺部并发症及死亡率的预测因素。
Ann Surg. 2004 Nov;240(5):791-800. doi: 10.1097/01.sla.0000143123.24556.1c.
10
Reducing hospital morbidity and mortality following esophagectomy.降低食管癌切除术后的医院发病率和死亡率。
Ann Thorac Surg. 2004 Oct;78(4):1170-6; discussion 1170-6. doi: 10.1016/j.athoracsur.2004.02.034.

麦基翁食管胃切除术

Mckeown esophagogastrectomy.

作者信息

D'Amico Thomas A

机构信息

Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

J Thorac Dis. 2014 May;6 Suppl 3(Suppl 3):S322-4. doi: 10.3978/j.issn.2072-1439.2014.03.28.

DOI:10.3978/j.issn.2072-1439.2014.03.28
PMID:24876937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4037420/
Abstract

Esophageal cancer is increasing in incidence faster than other cancers in the US. Outcomes after esophagectomy may be related to many factors, including the age of the patient, the stage of the tumor, the operative approach, and the incidence of postoperative morbidity. Pulmonary complications are the major source of morbidity and mortality following esophageal resection, and numerous studies have identified various factors associated with these complications. Various operative approaches have been applied to the management of esophageal cancer, with the goal of optimal oncologic results with the lowest possible morbidity and mortality. The McKeown esophagogastrectomy is applicable for most patients with esophageal cancer, and the technique and results are reviewed.

摘要

在美国,食管癌发病率的增长速度比其他癌症更快。食管切除术后的结果可能与许多因素有关,包括患者年龄、肿瘤分期、手术方式以及术后并发症的发生率。肺部并发症是食管切除术后发病和死亡的主要原因,许多研究已经确定了与这些并发症相关的各种因素。为了以尽可能低的发病率和死亡率实现最佳的肿瘤学效果,人们已经采用了各种手术方式来治疗食管癌。麦克基翁食管胃切除术适用于大多数食管癌患者,本文将对该技术及其结果进行综述。